Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,304 papers from all fields of science
Search
Sign In
Create Free Account
Growth Hormone-Producing Pituitary Gland Neoplasm
Known as:
Somatotrophinoma
, Growth Hormone Secreting Tumor of Pituitary Gland
, Growth Hormone Secreting Neoplasm of the Pituitary
Expand
An adenoma or carcinoma of the anterior lobe of the pituitary gland that produces growth hormone.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
Adenohypophysial Cell
Base of skull structure
Bone structure of cranium
Brain
Expand
Narrower (1)
Pituitary growth hormone cell adenoma
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
T. Cuny
,
M. Pertuit
,
+22 authors
A. Barlier
European Journal of Endocrinology
2013
Corpus ID: 19344403
CONTEXT Germline mutations in the aryl hydrocarbon receptor interacting protein gene (AIP) have been identified in young patients…
Expand
Highly Cited
2012
Highly Cited
2012
Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?
P. Xekouki
,
K. Pacak
,
+16 authors
C. Stratakis
Journal of Clinical Endocrinology and Metabolism
2012
Corpus ID: 2184829
BACKGROUND Mutations in the subunits B, C, and D of succinate dehydrogenase (SDH) mitochondrial complex II have been associated…
Expand
Highly Cited
2011
Highly Cited
2011
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
M. Tichomirowa
,
A. Barlier
,
+31 authors
A. Beckers
European Journal of Endocrinology
2011
Corpus ID: 11785992
BACKGROUND Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young…
Expand
Review
2007
Review
2007
The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
A. Beckers
,
A. Daly
European Journal of Endocrinology
2007
Corpus ID: 31473178
Pituitary adenomas occur in a familial setting in multiple endocrine neoplasia type 1 (MEN1) and Carney's complex (CNC), which…
Expand
Highly Cited
2006
Highly Cited
2006
Clinical characterization of familial isolated pituitary adenomas.
Adrian F. Daly
,
M. Jaffrain-Rea
,
+23 authors
Albert Beckers
Journal of Clinical Endocrinology and Metabolism
2006
Corpus ID: 13828183
CONTEXT Familial pituitary adenomas occur rarely in the absence of multiple endocrine neoplasia type 1 (MEN1) and Carney complex…
Expand
Highly Cited
2006
Highly Cited
2006
FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer
I. Wolf
,
S. Bose
,
E. Williamson
,
C. Miller
,
B. Karlan
,
H. Koeffler
International Journal of Cancer
2006
Corpus ID: 28530943
The transcription factor Forkhead‐box A1 (Foxa1), a member of the FOX class of transcription factors, has been implicated in the…
Expand
Highly Cited
1999
Highly Cited
1999
Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas
D. Simpson
,
J. Bicknell
,
A. McNicol
,
R. Clayton
,
W. Farrell
Genes, Chromosomes and Cancer
1999
Corpus ID: 19429375
The cyclin‐dependent kinase inhibitor 2A/multiple tumor suppressor gene 1 (CDKN2A/MTS1/p16) plays an important role in the…
Expand
Highly Cited
1996
Highly Cited
1996
Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.
J. Burgess
,
J. Shepherd
,
V. Parameswaran
,
L. Hoffman
,
T. Greenaway
Journal of Clinical Endocrinology and Metabolism
1996
Corpus ID: 11376960
Prolactinomas and somatotropinomas are reported to be the pituitary lesions most frequently associated with multiple endocrine…
Expand
Highly Cited
1993
Highly Cited
1993
Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.
K. Kristjánsson
,
Andrew
,
+5 authors
Hughes
Journal of Clinical Investigation
1993
Corpus ID: 14910964
We have identified and characterized two mutations in the hormone binding domain of the vitamin D receptor (VDR) in patients with…
Expand
Highly Cited
1985
Highly Cited
1985
Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin.
G. Ceda
,
A. Hoffman
,
G. Silverberg
,
D. Wilson
,
R. Rosenfeld
Journal of Clinical Endocrinology and Metabolism
1985
Corpus ID: 25412246
GH secretion is stimulated by hypothalamic GH-releasing factor (GHRH) and inhibited by somatostatin. Since GH induces the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE